MCLA [2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, hydrochloride] *CAS 128322-44-1*
Ordering information
Price | |
Catalog Number | |
Unit Size | |
Quantity |
Additional ordering information
Telephone | 1-800-990-8053 |
Fax | 1-800-609-2943 |
sales@aatbio.com | |
International | See distributors |
Bulk request | Inquire |
Custom size | Inquire |
Shipping | Standard overnight for United States, inquire for international |
Physical properties
Molecular weight | 291.73 |
Solvent | DMSO |
Storage, safety and handling
H-phrase | H303, H313, H333 |
Hazard symbol | XN |
Intended use | Research Use Only (RUO) |
R-phrase | R20, R21, R22 |
Storage | Freeze (< -15 °C); Minimize light exposure |
UNSPSC | 12352200 |
Overview | SDSProtocol |
See also: Reactive Oxygen Species (ROS)
CAS 128322-44-1 | Molecular weight 291.73 |
MCLA has been used to assess superoxide formation in a variety of conditions, including neutrophil and macrophage activation, cultured cells and vascular tissue. By using MCLA chemiluminescence, in vivo superoxide production has been reported from the surface of liver, intestine, heart and lung. MCLA-amplified chemiluminescence is also used to determine the extracellular superoxide production from spermatozoa.
Calculators
Common stock solution preparation
Table 1. Volume of DMSO needed to reconstitute specific mass of MCLA [2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, hydrochloride] *CAS 128322-44-1* to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.
0.1 mg | 0.5 mg | 1 mg | 5 mg | 10 mg | |
1 mM | 342.783 µL | 1.714 mL | 3.428 mL | 17.139 mL | 34.278 mL |
5 mM | 68.557 µL | 342.783 µL | 685.565 µL | 3.428 mL | 6.856 mL |
10 mM | 34.278 µL | 171.391 µL | 342.783 µL | 1.714 mL | 3.428 mL |
Molarity calculator
Enter any two values (mass, volume, concentration) to calculate the third.
Mass (Calculate) | Molecular weight | Volume (Calculate) | Concentration (Calculate) | Moles | ||||
/ | = | x | = |
Images
References
View all 44 references: Citation Explorer
Development of imidazopyrazinone red-chemiluminescent probes for detecting superoxide anions via a chemiluminescence resonance energy transfer method
Authors: Teranishi K., undefined
Journal: Luminescence. (2006)
Authors: Teranishi K., undefined
Journal: Luminescence. (2006)
Chemiluminescent visualization of superoxide generated by Candida albicans
Authors: Masui S, Majima T, Nakamura K, Ito-Kuwa S, Takeo K, Aoki S.
Journal: Med Mycol (2004): 427
Authors: Masui S, Majima T, Nakamura K, Ito-Kuwa S, Takeo K, Aoki S.
Journal: Med Mycol (2004): 427
Effect of endocrine disruptor para-nonylphenol on the cell growth and oxygen radical generation in Escherichia coli mutant cells deficient in catalase and superoxide dismutase
Authors: Okai Y, Sato EF, Higashi-Okai K, Inoue M.
Journal: Free Radic Biol Med (2004): 1412
Authors: Okai Y, Sato EF, Higashi-Okai K, Inoue M.
Journal: Free Radic Biol Med (2004): 1412
Immunoglobulin G induces microglial superoxide production
Authors: Yoshida T, Tanaka M, Okamoto K.
Journal: Neurol Res (2002): 361
Authors: Yoshida T, Tanaka M, Okamoto K.
Journal: Neurol Res (2002): 361
Superoxide production in the islet of Langerhans detected by the MCLA chemiluminescence method
Authors: Sakurai T, Terakawa S.
Journal: Methods Mol Biol (2002): 203
Authors: Sakurai T, Terakawa S.
Journal: Methods Mol Biol (2002): 203
Chemiluminescence of superoxide generated by Candida albicans: differential effects of the superoxide generator paraquat on a wild-type strain and a respiratory mutant
Authors: Aoki S, Ito-Kuwa S, Nakamura K, Nakamura Y, Vidotto V, Takeo K.
Journal: Med Mycol (2002): 13
Authors: Aoki S, Ito-Kuwa S, Nakamura K, Nakamura Y, Vidotto V, Takeo K.
Journal: Med Mycol (2002): 13
Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat
Authors: Hasegawa T, Kikuyama M, Sakurai K, Kambayashi Y, Adachi M, Saniabadi AR, Kuwano H, Nakano M.
Journal: Liver (2002): 321
Authors: Hasegawa T, Kikuyama M, Sakurai K, Kambayashi Y, Adachi M, Saniabadi AR, Kuwano H, Nakano M.
Journal: Liver (2002): 321
In vivo measurement of superoxide in the cerebral cortex during anoxia-reoxygenation and ischemia-reperfusion
Authors: Yamaguchi K, Uematsu D, Itoh Y, Watanabe S, Fukuuchi Y.
Journal: Keio J Med (2002): 201
Authors: Yamaguchi K, Uematsu D, Itoh Y, Watanabe S, Fukuuchi Y.
Journal: Keio J Med (2002): 201
Sinusoidal endothelial cell injury by superoxide anion and iron in the Propionibacterium acnes-pretreated and lipopolysaccharide-stimulated rat liver
Authors: Hasegawa T, Nakano M, Hashimoto T, Hiraishi K, Suzuki K, Kuwano H.
Journal: Liver (2001): 415
Authors: Hasegawa T, Nakano M, Hashimoto T, Hiraishi K, Suzuki K, Kuwano H.
Journal: Liver (2001): 415
A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action
Authors: Sumi D, Hayashi T, Thakur NK, Jayach and ran M, Asai Y, Kano H, Matsui H, Iguchi A.
Journal: Atherosclerosis (2001): 347
Authors: Sumi D, Hayashi T, Thakur NK, Jayach and ran M, Asai Y, Kano H, Matsui H, Iguchi A.
Journal: Atherosclerosis (2001): 347
Application notes
Abbreviation of Common Chemical Compounds Related to Peptides
A New Robust No-Wash FLIPR Calcium Assay Kit for Screening GPCR and Calcium Channel Targets
A Novel Fluorescent Probe for Imaging and Detecting Hydroxyl Radical in Living Cells
A Novel NO Wash Probeniceid-Free Calcium Assay for Functional Analysis of GPCR and Calcium Channel Targets
Evaluation of FLIPR Calcium Assays for Screening GPCR and Calcium Channel Targets
A New Robust No-Wash FLIPR Calcium Assay Kit for Screening GPCR and Calcium Channel Targets
A Novel Fluorescent Probe for Imaging and Detecting Hydroxyl Radical in Living Cells
A Novel NO Wash Probeniceid-Free Calcium Assay for Functional Analysis of GPCR and Calcium Channel Targets
Evaluation of FLIPR Calcium Assays for Screening GPCR and Calcium Channel Targets
FAQ
Why should I use an absorbance ratio at A575nm/A605nm when using most of your Amplite® Colorimetric Assay Kits?
How should I reconstitute an NADPH standard?
How can I lyse my cells without lysing the nuclear membrane?
What are the differences between calcium ion indicators: Cal 520, Cal 520FF, and Cal 520N?
What is the best way to stain cells with Membrane Marker 1-43 (MM 1-43)?
How should I reconstitute an NADPH standard?
How can I lyse my cells without lysing the nuclear membrane?
What are the differences between calcium ion indicators: Cal 520, Cal 520FF, and Cal 520N?
What is the best way to stain cells with Membrane Marker 1-43 (MM 1-43)?